May 19, 2022MedStar Georgetown University Hospital Stem Cell Transplant and Cellular Immunotherapy Program, Blood and Marrow Collection Program, and Cell Therapy Manufacturing Facility Receive FACT Re-Accreditation
The Foundation for the Accreditation of Cellular Therapy (FACT) recognizes MedStar Georgetown University Hospital for excellence in adult allogeneic and autologous hematopoietic progenitor cellular th...
January 16, 2018
Patient and Family Advisory Council for Quality and Safety (PFACQS), Fall 2017 PFACQS stands for Patient and Family Advisory Council for Quality and Safety. It is a committee that meets quarterly and...
January 13, 2018
COLUMBIA, Maryland (September 13, 2018)—MedStar Health has joined more than 40 healthcare and patient advocacy organizations that today launched a targeted effort to improve the process of medical dia...
January 13, 2018Medicaid Expansion Under The Affordable Care Act Did Not Increase Access to Complex Surgeries For Low Income Patients
Researchers from MedStar-Georgetown Surgical Outcomes Research Center, under senior investigator, Waddah B. Al-Refaie, MD, FACS, found that the Affordable Care Act Medicaid expansion did not increase ...
January 04, 2018Only Top Ten Percent of Nation’s Hospitals Achieve the Quality Rating
January 04, 2018
Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascu...
December 14, 2017Innovative telehealth technology allows high-risk patients to be treated safely at home, a remarkable advance in modern medicine.